Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment.
about
Subcutaneous Biological Treatments for Moderate to Severe Psoriasis: Interpreting Safety Data by Network Meta-Analysis.Biological drugs for the treatment of psoriasis in a public health system.The index 'Treatment Duration Control' for enabling randomized controlled trials with variation in duration of treatment of chronic pain patientsAdherence to guidelines in the use of biological agents to treat psoriasis in Brazil.Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points.Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.Systemic therapies for psoriasis: an evidence-based update.Combination therapy of cyclosporine and anti-tumor necrosis factor α in psoriasis: a case series of 10 patients.Systematic review on the maintenance of response during systemic antipsoriatic therapy.Long-term drug survival and predictor analysis of the whole psoriatic patient population on biological therapy in Hungary.Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study.Comparative effectiveness of biologic therapies on improvements in quality of life in patients with psoriasis.[Phototherapy in the era of biologicals].Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil.Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre.Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study.Old and New Biological Therapies for Psoriasis.On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis.PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis.Cost-effectiveness of systemic treatments for moderate-to-severe psoriasis in the German health care setting.
P2860
Q31137103-72CFB3E7-70A6-4261-B96B-929CE91882D5Q34271894-D5D5866B-9A91-496E-8B38-CAEA90F3FB5DQ35013672-A6F46899-9E7E-4E83-BC98-B0EAA0A43281Q37628279-5CF57939-3B1A-4A2C-BD1E-215AE0E545FBQ38137277-65837C51-132F-4604-915F-E6B8960ED0BAQ38153077-62883EF3-6A65-4BFD-B1CD-D7A0F2BFBD3FQ38185297-B75AFE0B-24AE-4AC0-A102-C7F6DF21090BQ38339763-61A4F6C0-8FEE-4DD4-879E-DE1A71360339Q38568183-265F1BA8-2CF8-470C-B4FA-567623643710Q38633601-46F3789D-EA5C-438D-8D84-E3D916149679Q38812025-0A27B4C0-BEB1-4ABE-B7C3-D8F356DD2E02Q39601823-F376598B-2354-456E-B017-22E6E6A075CBQ40261663-63286576-7B5F-4AB8-89D5-083F4E0E0B6DQ43872006-EDDA3417-40E9-4006-8421-AABC2D37509CQ43991141-0A74AB4E-9B25-42D1-9E26-67BA81FAEC17Q44365951-9545F4A3-7390-465A-9FD9-7D909EFDB26BQ44920372-15494754-1ACA-4625-A2A3-76120AADD6C9Q46338726-E40BBDC3-F051-4528-948E-C354BAF1CE60Q47859049-D88CBA2F-F86F-4D9D-AB13-61662F63DB3AQ48051795-A7B967D2-92FC-4BE4-B8A5-273EDC8C5936Q50068335-E88ED094-5183-4365-BD5E-EA246764AA4DQ52855161-2E9DAF0B-E990-4BB3-9109-6602CAF95B09
P2860
Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Efficacy of systemic therapies ...... alysis of long-term treatment.
@ast
Efficacy of systemic therapies ...... alysis of long-term treatment.
@en
Efficacy of systemic therapies ...... alysis of long-term treatment.
@nl
type
label
Efficacy of systemic therapies ...... alysis of long-term treatment.
@ast
Efficacy of systemic therapies ...... alysis of long-term treatment.
@en
Efficacy of systemic therapies ...... alysis of long-term treatment.
@nl
prefLabel
Efficacy of systemic therapies ...... alysis of long-term treatment.
@ast
Efficacy of systemic therapies ...... alysis of long-term treatment.
@en
Efficacy of systemic therapies ...... alysis of long-term treatment.
@nl
P2093
P2860
P1476
Efficacy of systemic therapies ...... alysis of long-term treatment.
@en
P2093
D Pathirana
F Bachmann
S Rosumeck
P2860
P304
P356
10.1111/J.1468-3083.2012.04492.X
P577
2012-03-09T00:00:00Z